Sort
23,748 grants matching “melanoma”
Local blockade of IL10R on innate immune cells to mediate both innate and adaptive anti-tumor immunity
$263,034Danny Khalil · Sloan-Kettering Inst Can Research · K08 · FY2022 · CA
Local blockade of IL10R on innate immune cells to mediate both innate and adaptive anti-tumor immunity
$263,034Danny Khalil · Sloan-Kettering Inst Can Research · K08 · FY2023 · CA
Local blockade of IL10R on innate immune cells to mediate both innate and adaptive anti-tumor immunity
$263,034Danny Khalil · Sloan-Kettering Inst Can Research · K08 · FY2021 · CA
Local blockade of IL10R on innate immune cells to mediate both innate and adaptive anti-tumor immunity
$263,034Danny Khalil · Sloan-Kettering Inst Can Research · K08 · FY2020 · CA
SSW Works: A Virtual Learning Environment for Occupational Skin Cancer Prevention
$263,012Mary K Buller · Klein Buendel, Inc. · R44 · FY2021 · CA
Molecular Design of Filopodia, Cell's Sensory Organelles
$263,002Tatyana Svitkina · University Of Pennsylvania · R01 · FY2008 · GM
Malignant melanoma: Regulation by AP-2 and PAR-1
$262,932Menashe Bareli · University Of Tx Md Anderson Can Ctr · R01 · FY2012 · CA
Malignant melanoma: Regulation by AP-2 and PAR-1
$262,932Menashe Bareli · University Of Tx Md Anderson Can Ctr · R01 · FY2011 · CA
Southwest Oncology Group
$262,855Heinz Josef Lenz · University Of Southern California · U10 · FY2009 · CA
Altering Post Vaccination T Cell Contraction
$262,800Medical University Of South Carolina · R01 · FY2005 · CA
Altering Post Vaccination T Cell Contraction
$262,800Medical University Of South Carolina · R01 · FY2004 · CA
Core 3-Biostatistics
$262,795J. Jack Lee · University Of Tx Md Anderson Can Ctr · P50 · FY2022 · CA
Core 3-Biostatistics
$262,794J. Jack Lee · University Of Tx Md Anderson Can Ctr · P50 · FY2019 · CA
Project 3
$262,762Michelle Krogsgaard · New York University School Of Medicine · P50 · FY2019 · CA
Phase II Study of Imatinib Mesylate in Patients with Inoperable Melanoma
$262,755Gary K Schwartz · Sloan-Kettering Inst Can Research · R01 · FY2008 · FD
Generation of T-cell receptors recognizing antigens on non-melanoma tumors
$262,744James C Yang · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
ENHANCED MELANOMA VACCINE AGAINST NEOANTIGENS AND SHARED ANTIGENS BY CD40 ACTIVATION AND TLR AGONISTS
$262,741The Cleveland Clinic Foundation · · FY2019 · Defense Health Agency
Tumorigenic moisturizing creams: mechanisms and active constituents
$262,728Yaoping Lu · Rutgers, The State Univ Of N.J. · R01 · FY2013 · CA
Rescuing CTL from Activation Induced Death
$262,700Bijay Mukherji · University Of Connecticut Sch Of Med/Dnt · R01 · FY2006 · CA
DNA Repair
$262,687Aziz Sancar · Univ Of North Carolina Chapel Hill · P01 · FY2011 · ES
Project 3: Mechanism-Based Design ofCombination Therapies for Pancreatic Cancer
$262,683Tayyaba Hasan · Massachusetts General Hospital · P01 · FY2018 · CA
Regulatory Network Differences/Diverse Tumor Subtypes/Design Combinatorial Therap
$262,672Chris Sander · Sloan-Kettering Inst Can Research · U54 · FY2011 · CA
BREAKING UNRESPONSIVENESS TO MAA WITH PETIDE MIMICS
$262,650Roswell Park Cancer Institute Corp · R01 · FY2001 · CA
PROLIFERATION &MALIGNANT TRANSFORMATION OF MELANOCYTES
$262,556Yale University · R01 · FY2000 · CA
TLR-mediated DC activation and immune reconstitution
$262,544Providence Portland Medical Center · R01 · FY2004 · CA